Related Experiment Videos
Ocular anti-inflammatory effect of fenoprofen. Dose-response study
Archives of Ophthalmology (Chicago, Ill. : 1960)
|July 1, 1975
Summary
Fenoprofen, a nonsteroidal anti-inflammatory drug, effectively treated experimental uveitis in rabbits at a 1% concentration. This dosage showed efficacy comparable to dexamethasone phosphate, offering a potential new treatment for ocular inflammation.
Area of Science:
- Ophthalmology
- Pharmacology
- Inflammation Research
Background:
- Uveitis is a significant cause of vision loss.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are explored for ocular inflammation.
- Fenoprofen is a propionic acid derivative with anti-inflammatory properties.
Purpose of the Study:
- To determine the optimal dose and efficacy of topical fenoprofen in a rabbit uveitis model.
- To compare fenoprofen's efficacy against a corticosteroid control.
Main Methods:
- An experimental rabbit uveitis model was utilized.
- Topical fenoprofen was administered at various concentrations (0.3% and 1%).
- Efficacy was assessed by comparing fenoprofen treatment groups to an untreated control and a dexamethasone phosphate group.
Main Results:
- Fenoprofen at 0.3% concentration showed no significant difference from the untreated group.
- A 3% fenoprofen concentration exhibited high ocular irritation.
- Fenoprofen 1% at pH 6.4 demonstrated significant efficacy, comparable to 0.1% dexamethasone phosphate.
Conclusions:
- Topical fenoprofen at 1% concentration is efficacious in managing experimental uveitis.
- Fenoprofen presents a viable alternative to corticosteroids for certain ocular inflammatory conditions.
- Further research into fenoprofen's safety and efficacy profile in ophthalmology is warranted.